ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 33092 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 33092; 2) Community: the network communities that were significantly associated with the response to NSC 33092; 3) Molecule: the relationships between components within communities and NSC 33092; 4) MDR: the compounds that were significantly associated with the NSC 33092.

NSC Compound Enrichment Correlation
NSC 757306 Pyrimethamine (USAN) 0.043472147060915 0.34872005
NSC 758664 Sirolimus [USAN] 0.043472147060915 0.10916657
NSC 761834 (Z)-5-chloro-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.043472147060915 0.13195886
NSC 89822 Null 0.043472147060915 0.3093085
NSC 12097 Resorufine 0.0434721470609156 0.22057593
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0434721470609156 0.27480338
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0434721470609156 0.57633833
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0434721470609156 0.1044783
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0434721470609156 0.52477315
NSC 176503 Fastigilin B 0.0434721470609156 0.11618849
Total:73  Current:68    [First] [Prev] [Next] [Last]